1	Modulation	Modulation	B-NP	NN	O	0	ROOT	16	Modulation
2	of	of	B-PP	IN	O	1	NMOD	-1
3	angiogenesis	angiogenesis	B-NP	NN	O	5	NMOD	3	angiogenesis
4	and	and	I-NP	CC	O	5	NMOD	-1
5	progelatinase	progelatinase	I-NP	NN	B-protein	2	PMOD	-1
6	a	a	O	DT	O	1	NMOD	-1
7	by	by	B-PP	IN	O	1	NMOD	-1
8	thrombin	thrombin	B-NP	NN	B-protein	10	NMOD	-1
9	receptor	receptor	I-NP	NN	I-protein	10	NMOD	-1
10	mimetics	mimetic	I-NP	NNS	O	12	NMOD	-1
11	and	and	I-NP	CC	O	12	NMOD	-1
12	antagonists	antagonist	I-NP	NNS	O	7	PMOD	-1
13	.	.	O	.	O	1	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	angiogenic	angiogenic	I-NP	JJ	O	3	NMOD	3	angiogenic
3	action	action	I-NP	NN	O	6	SUB	0
4	of	of	B-PP	IN	O	3	NMOD	-1
5	thrombin	thrombin	B-NP	NN	B-protein	4	PMOD	-1
6	has	have	B-VP	VBZ	O	0	ROOT	-1
7	been	be	I-VP	VBN	O	6	VC	-1
8	shown	show	I-VP	VBN	O	7	VC	-1
9	to	to	I-VP	TO	O	10	VMOD	-1
10	be	be	I-VP	VB	O	8	VMOD	-1
11	mediated	mediate	I-VP	VBN	O	10	VC	16	mediated
12	by	by	B-PP	IN	O	11	VMOD	-1
13	activation	activation	B-NP	NN	O	12	PMOD	17	activation
14	of	of	B-PP	IN	O	13	NMOD	-1
15	the	the	B-NP	DT	O	17	NMOD	-1
16	thrombin	thrombin	I-NP	NN	B-protein	17	NMOD	-1
17	receptor	receptor	I-NP	NN	I-protein	14	PMOD	-1
18	.	.	O	.	O	6	P	-1

1	In	In	B-PP	IN	O	5	VMOD	-1
2	this	this	B-NP	DT	O	3	NMOD	-1
3	report	report	I-NP	NN	O	1	PMOD	-1
4	we	we	B-NP	PRP	O	5	SUB	-1
5	studied	study	B-VP	VBD	O	0	ROOT	-1
6	the	the	B-NP	DT	O	7	NMOD	-1
7	effects	effect	I-NP	NNS	O	5	OBJ	16	effects
8	of	of	B-PP	IN	O	7	NMOD	-1
9	SFLLR	SFLLR	B-NP	NN	B-protein	12	NMOD	-1
10	,	,	O	,	O	12	P	-1
11	an	an	B-NP	DT	O	12	NMOD	-1
12	agonist	agonist	I-NP	NN	O	8	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	the	the	B-NP	DT	O	17	NMOD	-1
15	activated	activate	I-NP	VBN	O	17	NMOD	17	activated
16	thrombin	thrombin	I-NP	NN	B-protein	17	NMOD	-1
17	receptor	receptor	I-NP	NN	I-protein	21	NMOD	-1
18	and	and	I-NP	CC	O	21	NMOD	-1
19	thrombin	thrombin	I-NP	NN	B-protein	21	NMOD	-1
20	receptor	receptor	I-NP	NN	I-protein	21	NMOD	-1
21	peptide	peptide	I-NP	NN	O	25	NMOD	-1
22	and	and	O	CC	O	25	NMOD	-1
23	non	non	B-NP	JJ	O	25	NMOD	-1
24	peptide	peptide	I-NP	NN	O	25	NMOD	-1
25	antagonists	antagonist	I-NP	NNS	O	13	PMOD	-1
26	on	on	B-PP	IN	O	7	NMOD	-1
27	angiogenesis	angiogenesis	B-NP	NN	O	26	PMOD	3	angiogenesis
28	in	in	B-PP	IN	O	7	NMOD	-1
29	the	the	B-NP	DT	O	32	NMOD	-1
30	chick	chick	I-NP	NN	O	32	NMOD	-1
31	chorioallantoic	chorioallantoic	I-NP	JJ	O	32	NMOD	-1
32	membrane	membrane	I-NP	NN	O	36	NMOD	-1
33	(	(	O	(	O	35	DEP	-1
34	CAM	CAM	B-NP	NN	B-protein	35	DEP	-1
35	)	)	O	)	O	32	NMOD	-1
36	system	system	B-NP	NN	O	28	PMOD	0
37	.	.	O	.	O	5	P	-1

1	As	As	B-SBAR	IN	O	0	ROOT	-1
2	antagonists	antagonist	B-NP	NNS	O	3	SUB	-1
3	were	be	B-VP	VBD	O	1	VMOD	-1
4	used	use	I-VP	VBN	O	3	VC	0
5	the	the	B-NP	DT	O	7	NMOD	-1
6	tripeptide	tripeptide	I-NP	NN	O	7	NMOD	-1
7	FPR	FPR	I-NP	NN	O	9	NMOD	-1
8	and	and	O	CC	O	9	NMOD	-1
9	non-peptide	non-peptide	B-NP	NN	B-protein	14	NMOD	-1
10	1	1	I-NP	CD	I-protein	9	NMOD	-1
11	,	,	O	,	O	14	P	-1
12	4-disubstituted	4-disubstituted	B-NP	JJ	O	14	NMOD	-1
13	piperazine	piperazine	I-NP	NN	O	14	NMOD	-1
14	derivatives	derivative	I-NP	NNS	O	4	VMOD	-1
15	.	.	O	.	O	1	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	pentapeptide	pentapeptide	I-NP	NN	B-protein	3	NMOD	-1
3	SFLLR	SFLLR	I-NP	NN	I-protein	8	SUB	-1
4	,	,	O	,	O	3	P	-1
5	like	like	B-PP	IN	O	8	VMOD	-1
6	thrombin	thrombin	B-NP	NN	B-protein	5	PMOD	-1
7	,	,	O	,	O	8	P	-1
8	caused	cause	B-VP	VBD	O	0	ROOT	0
9	a	a	B-NP	DT	O	11	NMOD	-1
10	marked	marked	I-NP	JJ	O	11	NMOD	-1
11	stimulation	stimulation	I-NP	NN	O	8	OBJ	17	stimulation
12	of	of	B-PP	IN	O	11	NMOD	-1
13	angiogenesis	angiogenesis	B-NP	NN	O	12	PMOD	3	angiogenesis
14	in	in	B-PP	IN	O	8	VMOD	-1
15	the	the	B-NP	DT	O	16	NMOD	-1
16	CAM	CAM	I-NP	NN	B-protein	14	PMOD	-1
17	.	.	O	.	O	8	P	-1

1	FPR	FPR	B-NP	NN	B-protein	5	NMOD	-1
2	and	and	O	CC	O	5	NMOD	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	piperazine	piperazine	I-NP	NN	O	5	NMOD	-1
5	derivatives	derivative	I-NP	NNS	O	6	SUB	-1
6	caused	cause	B-VP	VBD	O	0	ROOT	0
7	suppression	suppression	B-NP	NN	O	6	OBJ	18	suppression
8	of	of	B-PP	IN	O	7	NMOD	-1
9	angiogenesis	angiogenesis	B-NP	NN	O	8	PMOD	3	angiogenesis
10	and	and	B-PP	CC	O	6	VMOD	-1
11	in	in	B-PP	IN	O	6	VMOD	-1
12	combination	combination	B-NP	NN	O	15	SUB	-1
13	with	with	B-PP	IN	O	12	NMOD	-1
14	thrombin	thrombin	B-NP	NN	B-protein	13	PMOD	-1
15	antagonized	antagonize	B-VP	VBD	O	11	SBAR	18	antagonized
16	its	its	B-NP	PRP$	O	18	NMOD	-1
17	angiogenic	angiogenic	I-NP	JJ	O	18	NMOD	3	angiogenic
18	effect	effect	I-NP	NN	O	15	OBJ	0
19	.	.	O	.	O	6	P	-1

1	Thrombin	Thrombin	B-NP	NN	B-protein	3	NMOD	-1
2	and	and	I-NP	CC	O	3	NMOD	-1
3	SFLLR	SFLLR	I-NP	NN	B-protein	4	SUB	-1
4	activated	activate	B-VP	VBD	I-protein	0	ROOT	17	activated
5	progelatinase	progelatinase	B-NP	NN	I-protein	6	NMOD	-1
6	A	A	I-NP	NN	I-protein	4	OBJ	-1
7	(	(	O	(	O	9	DEP	-1
8	MMP-2	MMP-2	B-NP	NN	B-protein	9	DEP	-1
9	)	)	O	)	O	6	NMOD	-1
10	in	in	B-PP	IN	O	6	NMOD	-1
11	the	the	B-NP	DT	O	13	NMOD	-1
12	culture	culture	I-NP	NN	O	13	NMOD	0
13	medium	medium	I-NP	NN	O	10	PMOD	-1
14	of	of	B-PP	IN	O	13	NMOD	-1
15	human	human	B-NP	JJ	B-cell_type	19	NMOD	-1
16	umbilical	umbilical	I-NP	JJ	I-cell_type	19	NMOD	-1
17	cord	cord	I-NP	NN	I-cell_type	19	NMOD	-1
18	endothelial	endothelial	I-NP	JJ	I-cell_type	19	NMOD	-1
19	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	-1
20	(	(	O	(	O	22	DEP	-1
21	HUVECs	HUVEC	B-NP	NNS	B-cell_line	22	DEP	-1
22	)	)	O	)	O	19	NMOD	-1
23	.	.	O	.	O	4	P	-1

1	MMP-2	MMP-2	B-NP	NN	B-protein	2	SUB	-1
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	involved	involve	I-VP	VBN	O	2	VC	0
4	in	in	B-PP	IN	O	3	VMOD	-1
5	the	the	B-NP	DT	O	7	NMOD	-1
6	early	early	I-NP	JJ	O	7	NMOD	-1
7	steps	step	I-NP	NNS	O	4	PMOD	-1
8	of	of	B-PP	IN	O	7	NMOD	-1
9	angiogenesis	angiogenesis	B-NP	NN	O	8	PMOD	3	angiogenesis
10	leading	lead	B-VP	VBG	O	9	NMOD	17	leading
11	to	to	B-PP	TO	O	10	VMOD	-1
12	local	local	B-NP	JJ	O	13	NMOD	-1
13	dissolution	dissolution	I-NP	NN	O	11	PMOD	11	dissolution
14	of	of	B-PP	IN	O	13	NMOD	-1
15	basement	basement	B-NP	NN	B-protein	17	NMOD	-1
16	membrane	membrane	I-NP	NN	I-protein	17	NMOD	-1
17	collagen	collagen	I-NP	NN	I-protein	19	NMOD	-1
18	and	and	I-NP	CC	O	19	NMOD	-1
19	migration	migration	I-NP	NN	O	14	PMOD	14	migration
20	of	of	B-PP	IN	O	19	NMOD	-1
21	the	the	B-NP	DT	O	24	NMOD	-1
22	activated	activate	I-NP	VBN	B-cell_type	24	NMOD	17	activated
23	endothelial	endothelial	I-NP	JJ	I-cell_type	24	NMOD	-1
24	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	-1
25	.	.	O	.	O	2	P	-1

1	FPR	FPR	B-NP	NN	B-protein	5	NMOD	-1
2	and	and	O	CC	O	5	NMOD	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	piperazine	piperazine	I-NP	NN	O	5	NMOD	-1
5	derivatives	derivative	I-NP	NNS	O	6	SUB	-1
6	inhibited	inhibit	B-VP	VBD	O	0	ROOT	18	inhibited
7	the	the	B-NP	DT	O	8	NMOD	-1
8	activation	activation	I-NP	NN	O	6	OBJ	17	activation
9	of	of	B-PP	IN	O	8	NMOD	-1
10	this	this	B-NP	DT	O	11	NMOD	-1
11	enzyme	enzyme	I-NP	NN	B-protein	9	PMOD	-1
12	.	.	O	.	O	6	P	-1

1	They	They	B-NP	PRP	O	3	SUB	-1
2	also	also	B-ADVP	RB	O	3	VMOD	-1
3	antagonised	antagonise	B-VP	VBD	O	0	ROOT	18	antagonised
4	the	the	B-NP	DT	O	5	NMOD	-1
5	effects	effect	I-NP	NNS	O	3	OBJ	16	effects
6	of	of	B-PP	IN	O	5	NMOD	-1
7	both	both	O	CC	O	10	NMOD	-1
8	thrombin	thrombin	B-NP	NN	B-protein	10	NMOD	-1
9	and	and	O	CC	O	10	NMOD	-1
10	SFLLR	SFLLR	B-NP	NN	B-protein	6	PMOD	-1
11	on	on	B-PP	IN	O	5	NMOD	-1
12	MMP-2	MMP-2	B-NP	NN	B-protein	13	NMOD	-1
13	activation	activation	I-NP	NN	O	11	PMOD	17	activation
14	.	.	O	.	O	3	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	3	SUB	0
3	suggest	suggest	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	non-thrombogenic	non-thrombogenic	B-NP	JJ	O	8	NMOD	-1
6	agonists	agonist	I-NP	NNS	O	8	NMOD	-1
7	or	or	I-NP	CC	O	8	NMOD	-1
8	antagonists	antagonist	I-NP	NNS	O	14	SUB	-1
9	of	of	B-PP	IN	O	8	NMOD	-1
10	the	the	B-NP	DT	O	13	NMOD	-1
11	activated	activate	I-NP	VBN	O	13	NMOD	17	activated
12	thrombin	thrombin	I-NP	NN	B-protein	13	NMOD	-1
13	receptor	receptor	I-NP	NN	I-protein	9	PMOD	-1
14	can	can	B-VP	MD	O	4	SBAR	-1
15	be	be	I-VP	VB	O	14	VC	-1
16	used	use	I-VP	VBN	O	15	VC	0
17	as	as	B-PP	IN	O	16	VMOD	-1
18	modulators	modulator	B-NP	NNS	O	17	PMOD	16	modulators
19	of	of	B-PP	IN	O	18	NMOD	-1
20	angiogenesis	angiogenesis	B-NP	NN	O	19	PMOD	3	angiogenesis
21	.	.	O	.	O	3	P	-1

